For the year ending 2025-12-31, JAGX has $38,323K in assets. $57,011K in debts. $968K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash | 968 | |||
| Restricted cash | 6,864 | |||
| Accounts receivable, net | 1,521 | |||
| Other receivable | 177 | |||
| Inventory, net | 8,599 | |||
| Prepaid expenses and other current assets | 2,216 | |||
| Total current assets | 20,345 | |||
| Total property and equipment at cost | 1,021 | |||
| Accumulated depreciation | 558 | |||
| Property and equipment, net | 463 | |||
| Operating lease - right-of-use asset | 1,000 | |||
| Intangible assets, net | 16,021 | |||
| Other assets | 494 | |||
| Total assets | 38,323 | |||
| Accounts payable | 8,686 | |||
| Accrued liabilities | 4,166 | |||
| Deferred revenue | 170 | |||
| Operating lease liability, current | 192 | |||
| Notes payable, net of discount (includes note designated at fair value option amounting to 26.2 million as of december 31, 2025, and 11.9 million as of december 31, 2024, respectively) | 27,440 | |||
| Total current liabilities | 40,654 | |||
| Operating lease liability, net of current portion | 892 | |||
| Deferred revenue, net of current portion | 382 | |||
| Notes payable, net of discount, net of current portion (includes notes designated at fair value option amounting to 5.7 million as of december 31, 2025, and 23.5 million as of december 31, 2024, respectively) | 15,083 | |||
| Total liabilities | 57,011 | |||
| Preferred stock value-Series LPerpetual Preferred Stock | 2,485 | |||
| Common stock value-Common Stock Voting | 1 | |||
| Common stock value-Nonvoting Common Stock | 0 | |||
| Additional paid-in capital | 380,974 | |||
| Noncontrolling interest | -1,399 | |||
| Accumulated deficit | -399,916 | |||
| Accumulated other comprehensive loss | -833 | |||
| Total stockholders' equity (deficit) | -18,688 | |||
| Total liabilities, redeemable preferred stock and stockholders' equity (deficit) | 38,323 | |||
Jaguar Health, Inc. (JAGX)
Jaguar Health, Inc. (JAGX)